Switch to EGFR-TKI after upfront platinum doublet induction therapy in non-small cell lung cancer (NSCLC) patients with EGFR (Epidermal Growth Factor Receptor) mutation: A multicentre retrospective study
- Resource Type
- Article
- Source
- In
Cancer Treatment and Research Communications 2022 31 - Subject
- Language
- ISSN
- 2468-2942